

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 5.60727543 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.60727543 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.46996713 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.46996713 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.05935556 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.81312854 |
| 7 | negative regulation of interleukin-12 production (GO:0032695) | 4.66296103 |
| 8 | positive regulation of interferon-alpha production (GO:0032727) | 4.54311838 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 4.51243269 |
| 10 | response to interferon-alpha (GO:0035455) | 4.41305858 |
| 11 | detection of other organism (GO:0098543) | 4.38395244 |
| 12 | response to interferon-beta (GO:0035456) | 4.27882813 |
| 13 | regulation of interferon-alpha production (GO:0032647) | 4.27366824 |
| 14 | regulation of gamma-delta T cell activation (GO:0046643) | 4.11601724 |
| 15 | leukocyte aggregation (GO:0070486) | 4.11523049 |
| 16 | detection of bacterium (GO:0016045) | 4.10823063 |
| 17 | cellular response to type I interferon (GO:0071357) | 4.02553663 |
| 18 | type I interferon signaling pathway (GO:0060337) | 4.02553663 |
| 19 | response to type I interferon (GO:0034340) | 4.02348317 |
| 20 | cellular extravasation (GO:0045123) | 3.97218535 |
| 21 | cellular response to interferon-beta (GO:0035458) | 3.93868857 |
| 22 | response to interleukin-15 (GO:0070672) | 3.89036096 |
| 23 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.88467135 |
| 24 | detection of external biotic stimulus (GO:0098581) | 3.85146943 |
| 25 | positive regulation by symbiont of host defense response (GO:0052509) | 3.81679591 |
| 26 | modulation by symbiont of host defense response (GO:0052031) | 3.81679591 |
| 27 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.81679591 |
| 28 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.81679591 |
| 29 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.81679591 |
| 30 | modulation by symbiont of host immune response (GO:0052553) | 3.81679591 |
| 31 | microglial cell activation (GO:0001774) | 3.81629769 |
| 32 | negative regulation of viral genome replication (GO:0045071) | 3.71853934 |
| 33 | negative regulation of T cell mediated immunity (GO:0002710) | 3.70526065 |
| 34 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.70212570 |
| 35 | immunoglobulin mediated immune response (GO:0016064) | 3.66891420 |
| 36 | response to peptidoglycan (GO:0032494) | 3.66828276 |
| 37 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.60047203 |
| 38 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.59514953 |
| 39 | cellular response to interleukin-15 (GO:0071350) | 3.55202761 |
| 40 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.52572755 |
| 41 | macrophage activation (GO:0042116) | 3.50946998 |
| 42 | regulation of RIG-I signaling pathway (GO:0039535) | 3.49862456 |
| 43 | detection of biotic stimulus (GO:0009595) | 3.45193742 |
| 44 | respiratory burst (GO:0045730) | 3.44436414 |
| 45 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.43302304 |
| 46 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.43071257 |
| 47 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.41581689 |
| 48 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.37355924 |
| 49 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.34344452 |
| 50 | regulation of T cell tolerance induction (GO:0002664) | 3.29900646 |
| 51 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.25471163 |
| 52 | activated T cell proliferation (GO:0050798) | 3.24827793 |
| 53 | defense response to protozoan (GO:0042832) | 3.22271906 |
| 54 | regulation of tolerance induction (GO:0002643) | 3.21333176 |
| 55 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.19888901 |
| 56 | natural killer cell mediated immunity (GO:0002228) | 3.19888901 |
| 57 | positive regulation of interleukin-17 production (GO:0032740) | 3.18567507 |
| 58 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.17702163 |
| 59 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.17702163 |
| 60 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.16856913 |
| 61 | cellular response to exogenous dsRNA (GO:0071360) | 3.13982302 |
| 62 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.13924186 |
| 63 | regulation of regulatory T cell differentiation (GO:0045589) | 3.12763719 |
| 64 | positive regulation of interferon-beta production (GO:0032728) | 3.11302305 |
| 65 | cellular response to zinc ion (GO:0071294) | 3.10560315 |
| 66 | regulation of mast cell degranulation (GO:0043304) | 3.10450718 |
| 67 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.10422674 |
| 68 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.09864448 |
| 69 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.09864448 |
| 70 | leukocyte degranulation (GO:0043299) | 3.09685090 |
| 71 | regulation of B cell differentiation (GO:0045577) | 3.08837145 |
| 72 | B cell mediated immunity (GO:0019724) | 3.08415359 |
| 73 | B cell receptor signaling pathway (GO:0050853) | 3.08144183 |
| 74 | response to protozoan (GO:0001562) | 3.08068159 |
| 75 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.07790489 |
| 76 | regulation of mast cell activation (GO:0033003) | 3.07655556 |
| 77 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.06647793 |
| 78 | T cell migration (GO:0072678) | 3.06024347 |
| 79 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.04783478 |
| 80 | negative T cell selection (GO:0043383) | 3.04110664 |
| 81 | tolerance induction (GO:0002507) | 3.03379346 |
| 82 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.02177890 |
| 83 | germinal center formation (GO:0002467) | 3.01208945 |
| 84 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.01175098 |
| 85 | positive regulation of tolerance induction (GO:0002645) | 3.01092079 |
| 86 | positive regulation of mast cell activation (GO:0033005) | 3.00408685 |
| 87 | regulation of growth of symbiont in host (GO:0044126) | 3.00372505 |
| 88 | negative regulation of growth of symbiont in host (GO:0044130) | 3.00372505 |
| 89 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.00372505 |
| 90 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.00372505 |
| 91 | negative thymic T cell selection (GO:0045060) | 2.99477215 |
| 92 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.99365118 |
| 93 | reactive oxygen species biosynthetic process (GO:1903409) | 2.99099525 |
| 94 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.98951008 |
| 95 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.96169066 |
| 96 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.95862157 |
| 97 | positive thymic T cell selection (GO:0045059) | 2.95632530 |
| 98 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.95028067 |
| 99 | macrophage activation involved in immune response (GO:0002281) | 2.94326703 |
| 100 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.91196459 |
| 101 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.91078663 |
| 102 | negative regulation of innate immune response (GO:0045824) | 2.89526862 |
| 103 | myeloid leukocyte mediated immunity (GO:0002444) | 2.88891320 |
| 104 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.88334217 |
| 105 | neutrophil activation (GO:0042119) | 2.88223288 |
| 106 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.87736084 |
| 107 | granulocyte activation (GO:0036230) | 2.87725913 |
| 108 | positive regulation of B cell differentiation (GO:0045579) | 2.86726009 |
| 109 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.86689329 |
| 110 | regulation of chemokine biosynthetic process (GO:0045073) | 2.84238264 |
| 111 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.84237134 |
| 112 | response to muramyl dipeptide (GO:0032495) | 2.83886952 |
| 113 | cellular response to interferon-alpha (GO:0035457) | 2.83419192 |
| 114 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.82678866 |
| 115 | response to host immune response (GO:0052572) | 2.82678866 |
| 116 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.81455377 |
| 117 | myeloid cell activation involved in immune response (GO:0002275) | 2.78545624 |
| 118 | T-helper 1 type immune response (GO:0042088) | 2.78488002 |
| 119 | myeloid dendritic cell activation (GO:0001773) | 2.76898658 |
| 120 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.76412730 |
| 121 | negative regulation of phagocytosis (GO:0050765) | 2.74475256 |
| 122 | leukocyte mediated cytotoxicity (GO:0001909) | 2.71748653 |
| 123 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.69840867 |
| 124 | cellular response to virus (GO:0098586) | 2.68146233 |
| 125 | myeloid dendritic cell differentiation (GO:0043011) | 2.67034303 |
| 126 | actin nucleation (GO:0045010) | 2.66055328 |
| 127 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.65467660 |
| 128 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.64349739 |
| 129 | neutrophil mediated immunity (GO:0002446) | 2.61059106 |
| 130 | defense response to virus (GO:0051607) | 2.60800555 |
| 131 | ribosomal small subunit assembly (GO:0000028) | 2.59620466 |
| 132 | regulation of necroptotic process (GO:0060544) | 2.59564575 |
| 133 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.59455582 |
| 134 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.58783554 |
| 135 | response to fungus (GO:0009620) | 2.57860092 |
| 136 | regulation of natural killer cell differentiation (GO:0032823) | 2.55334561 |
| 137 | response to host (GO:0075136) | 2.54974546 |
| 138 | response to host defenses (GO:0052200) | 2.54974546 |
| 139 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.54974546 |
| 140 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.54889248 |
| 141 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.53859294 |
| 142 | positive regulation of response to biotic stimulus (GO:0002833) | 2.47120256 |
| 143 | detection of molecule of bacterial origin (GO:0032490) | 2.44690312 |
| 144 | dendritic cell differentiation (GO:0097028) | 2.44054180 |
| 145 | angiogenesis involved in wound healing (GO:0060055) | 2.44052197 |
| 146 | purine-containing compound salvage (GO:0043101) | 2.43020235 |
| 147 | positive regulation of antigen processing and presentation (GO:0002579) | 2.42447380 |
| 148 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.41312538 |
| 149 | positive regulation of type I interferon production (GO:0032481) | 2.39520326 |
| 150 | superoxide anion generation (GO:0042554) | 2.39363401 |
| 151 | cytoplasmic pattern recognition receptor signaling pathway (GO:0002753) | 2.38558351 |
| 152 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.36837874 |
| 153 | myeloid leukocyte activation (GO:0002274) | 2.35678217 |
| 154 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.35415506 |
| 155 | NIK/NF-kappaB signaling (GO:0038061) | 2.35317218 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.79945762 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.69677660 |
| 3 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.58858941 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.93190410 |
| 5 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.72866272 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.27032648 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.09828298 |
| 8 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.05686203 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.03246153 |
| 10 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.84685316 |
| 11 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.83363536 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.76337081 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.69475220 |
| 14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.64662324 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.51373581 |
| 16 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.41274799 |
| 17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.40258889 |
| 18 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.31401209 |
| 19 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.28765656 |
| 20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.18953450 |
| 21 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.14966902 |
| 22 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.06026426 |
| 23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.05899670 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.03868371 |
| 25 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.99610961 |
| 26 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.99399504 |
| 27 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.98013425 |
| 28 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.97516543 |
| 29 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.96591088 |
| 30 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90727657 |
| 31 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.83664917 |
| 32 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.83177769 |
| 33 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.81968400 |
| 34 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.78607985 |
| 35 | GATA1_22025678_ChIP-Seq_K562_Human | 1.76764610 |
| 36 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.75327913 |
| 37 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.72183345 |
| 38 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69317946 |
| 39 | MYB_26560356_Chip-Seq_TH2_Human | 1.68684452 |
| 40 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.66631108 |
| 41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.63282827 |
| 42 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.62414688 |
| 43 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53071227 |
| 44 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.50105761 |
| 45 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.48749721 |
| 46 | MYB_26560356_Chip-Seq_TH1_Human | 1.46755708 |
| 47 | MAF_26560356_Chip-Seq_TH1_Human | 1.46637052 |
| 48 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.46169451 |
| 49 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.42780193 |
| 50 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.42512547 |
| 51 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.38361602 |
| 52 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.38006659 |
| 53 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.36417009 |
| 54 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.36246036 |
| 55 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.34734869 |
| 56 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.33549900 |
| 57 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.31492721 |
| 58 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31305503 |
| 59 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.28256998 |
| 60 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.27741406 |
| 61 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.26775875 |
| 62 | MYC_22102868_ChIP-Seq_BL_Human | 1.26755069 |
| 63 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.26722525 |
| 64 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.26477842 |
| 65 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24744603 |
| 66 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.23239393 |
| 67 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22414255 |
| 68 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.22152626 |
| 69 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19285852 |
| 70 | UTX_26944678_Chip-Seq_JUKART_Human | 1.17104315 |
| 71 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.16430227 |
| 72 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.14712636 |
| 73 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13975260 |
| 74 | * NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.13802172 |
| 75 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.13561442 |
| 76 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.13482027 |
| 77 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.12878223 |
| 78 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12707677 |
| 79 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12394575 |
| 80 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.11766342 |
| 81 | SPI1_23127762_ChIP-Seq_K562_Human | 1.11119688 |
| 82 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09251497 |
| 83 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.07449823 |
| 84 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07183794 |
| 85 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.06163753 |
| 86 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.05297237 |
| 87 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.04767419 |
| 88 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.04691330 |
| 89 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.04624885 |
| 90 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.04454017 |
| 91 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.04293369 |
| 92 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03190123 |
| 93 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.02585709 |
| 94 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.02491598 |
| 95 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.01484595 |
| 96 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01333445 |
| 97 | GATA1_19941826_ChIP-Seq_K562_Human | 1.00896538 |
| 98 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.98735001 |
| 99 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98673363 |
| 100 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97814483 |
| 101 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.97306890 |
| 102 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.97091227 |
| 103 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.96878030 |
| 104 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95935394 |
| 105 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.94643351 |
| 106 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.94563155 |
| 107 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.93985078 |
| 108 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93885225 |
| 109 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.92835420 |
| 110 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.92465659 |
| 111 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.91928738 |
| 112 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90808995 |
| 113 | MAF_26560356_Chip-Seq_TH2_Human | 0.89698549 |
| 114 | GATA3_26560356_Chip-Seq_TH2_Human | 0.89622614 |
| 115 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.89543991 |
| 116 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.89513043 |
| 117 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.88891064 |
| 118 | GATA2_19941826_ChIP-Seq_K562_Human | 0.87942389 |
| 119 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.87847383 |
| 120 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.87803963 |
| 121 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.86624516 |
| 122 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.86426882 |
| 123 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.86214035 |
| 124 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.86121360 |
| 125 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.85800877 |
| 126 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.85596577 |
| 127 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.84941562 |
| 128 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.79832188 |
| 129 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.79370010 |
| 130 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.76366681 |
| 131 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.72847238 |
| 132 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72838207 |
| 133 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70616297 |
| 134 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.69844491 |
| 135 | GATA3_26560356_Chip-Seq_TH1_Human | 0.68708292 |
| 136 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.66716253 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.86178027 |
| 2 | MP0009785_altered_susceptibility_to | 3.44602395 |
| 3 | MP0003436_decreased_susceptibility_to | 3.00290807 |
| 4 | MP0003724_increased_susceptibility_to | 2.91613161 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 2.85167100 |
| 6 | MP0002419_abnormal_innate_immunity | 2.62916128 |
| 7 | MP0005025_abnormal_response_to | 2.61961720 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.42539958 |
| 9 | MP0000685_abnormal_immune_system | 2.35691689 |
| 10 | MP0001853_heart_inflammation | 2.31309890 |
| 11 | MP0005671_abnormal_response_to | 2.28627840 |
| 12 | MP0002452_abnormal_antigen_presenting | 2.20846739 |
| 13 | MP0003303_peritoneal_inflammation | 2.18698386 |
| 14 | MP0002396_abnormal_hematopoietic_system | 2.16708922 |
| 15 | MP0005464_abnormal_platelet_physiology | 2.13566865 |
| 16 | MP0005387_immune_system_phenotype | 2.08785797 |
| 17 | MP0001790_abnormal_immune_system | 2.08785797 |
| 18 | MP0002723_abnormal_immune_serum | 2.05132208 |
| 19 | MP0010352_gastrointestinal_tract_polyps | 2.04508080 |
| 20 | MP0001800_abnormal_humoral_immune | 2.03587230 |
| 21 | MP0002166_altered_tumor_susceptibility | 2.03131457 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 2.01821329 |
| 23 | MP0008438_abnormal_cutaneous_collagen | 2.01219390 |
| 24 | MP0006082_CNS_inflammation | 1.98611510 |
| 25 | MP0001819_abnormal_immune_cell | 1.94380328 |
| 26 | MP0002420_abnormal_adaptive_immunity | 1.92670345 |
| 27 | MP0001533_abnormal_skeleton_physiology | 1.90953315 |
| 28 | MP0010155_abnormal_intestine_physiology | 1.90584252 |
| 29 | MP0002006_tumorigenesis | 1.88746575 |
| 30 | MP0004808_abnormal_hematopoietic_stem | 1.87174561 |
| 31 | MP0010307_abnormal_tumor_latency | 1.86465298 |
| 32 | MP0005397_hematopoietic_system_phenotyp | 1.84880411 |
| 33 | MP0001545_abnormal_hematopoietic_system | 1.84880411 |
| 34 | MP0000343_altered_response_to | 1.74230123 |
| 35 | MP0006054_spinal_hemorrhage | 1.64018004 |
| 36 | MP0000858_altered_metastatic_potential | 1.63827535 |
| 37 | MP0003705_abnormal_hypodermis_morpholog | 1.62868792 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.62489473 |
| 39 | MP0002398_abnormal_bone_marrow | 1.62464705 |
| 40 | MP0001845_abnormal_inflammatory_respons | 1.62364460 |
| 41 | MP0003448_altered_tumor_morphology | 1.62281642 |
| 42 | MP0005058_abnormal_lysosome_morphology | 1.60078002 |
| 43 | MP0004947_skin_inflammation | 1.58312457 |
| 44 | MP0000490_abnormal_crypts_of | 1.58115504 |
| 45 | MP0009764_decreased_sensitivity_to | 1.57244435 |
| 46 | MP0002405_respiratory_system_inflammati | 1.53709659 |
| 47 | MP0000716_abnormal_immune_system | 1.52928705 |
| 48 | MP0008469_abnormal_protein_level | 1.51627447 |
| 49 | MP0008260_abnormal_autophagy | 1.49254694 |
| 50 | MP0003186_abnormal_redox_activity | 1.45693275 |
| 51 | MP0003172_abnormal_lysosome_physiology | 1.45684674 |
| 52 | MP0009278_abnormal_bone_marrow | 1.43688909 |
| 53 | MP0003183_abnormal_peptide_metabolism | 1.41735796 |
| 54 | MP0005451_abnormal_body_composition | 1.41719222 |
| 55 | MP0002429_abnormal_blood_cell | 1.36826921 |
| 56 | MP0000689_abnormal_spleen_morphology | 1.34934298 |
| 57 | MP0002877_abnormal_melanocyte_morpholog | 1.31781162 |
| 58 | MP0003300_gastrointestinal_ulcer | 1.30327170 |
| 59 | MP0002138_abnormal_hepatobiliary_system | 1.29636249 |
| 60 | MP0002277_abnormal_respiratory_mucosa | 1.28280415 |
| 61 | MP0000569_abnormal_digit_pigmentation | 1.27801572 |
| 62 | MP0002722_abnormal_immune_system | 1.27494491 |
| 63 | MP0003806_abnormal_nucleotide_metabolis | 1.25952668 |
| 64 | MP0004883_abnormal_blood_vessel | 1.25334374 |
| 65 | MP0002132_abnormal_respiratory_system | 1.23894803 |
| 66 | MP0005023_abnormal_wound_healing | 1.21361364 |
| 67 | MP0003566_abnormal_cell_adhesion | 1.20188649 |
| 68 | MP0005174_abnormal_tail_pigmentation | 1.19942011 |
| 69 | MP0003693_abnormal_embryo_hatching | 1.19677357 |
| 70 | MP0003763_abnormal_thymus_physiology | 1.15732815 |
| 71 | MP0009840_abnormal_foam_cell | 1.13361360 |
| 72 | MP0003075_altered_response_to | 1.12016980 |
| 73 | MP0009763_increased_sensitivity_to | 1.10407408 |
| 74 | MP0004381_abnormal_hair_follicle | 1.09972361 |
| 75 | MP0005164_abnormal_response_to | 1.09002416 |
| 76 | MP0008007_abnormal_cellular_replicative | 1.07636619 |
| 77 | MP0004510_myositis | 1.06014847 |
| 78 | MP0002998_abnormal_bone_remodeling | 1.00519009 |
| 79 | MP0001663_abnormal_digestive_system | 0.99906349 |
| 80 | MP0000465_gastrointestinal_hemorrhage | 0.99499336 |
| 81 | MP0001873_stomach_inflammation | 0.99375841 |
| 82 | MP0002019_abnormal_tumor_incidence | 0.98003098 |
| 83 | MP0003279_aneurysm | 0.97224571 |
| 84 | MP0005390_skeleton_phenotype | 0.92308722 |
| 85 | MP0000249_abnormal_blood_vessel | 0.89599042 |
| 86 | MP0003091_abnormal_cell_migration | 0.88257386 |
| 87 | MP0001879_abnormal_lymphatic_vessel | 0.86671942 |
| 88 | MP0005360_urolithiasis | 0.85387559 |
| 89 | MP0005166_decreased_susceptibility_to | 0.85159490 |
| 90 | MP0003828_pulmonary_edema | 0.85009750 |
| 91 | MP0010094_abnormal_chromosome_stability | 0.84883352 |
| 92 | MP0001851_eye_inflammation | 0.84821483 |
| 93 | MP0003656_abnormal_erythrocyte_physiolo | 0.84548589 |
| 94 | MP0001958_emphysema | 0.84267330 |
| 95 | MP0005167_abnormal_blood-brain_barrier | 0.83576748 |
| 96 | MP0003045_fibrosis | 0.82726963 |
| 97 | MP0010368_abnormal_lymphatic_system | 0.82012583 |
| 98 | MP0003690_abnormal_glial_cell | 0.81368575 |
| 99 | MP0005310_abnormal_salivary_gland | 0.80006560 |
| 100 | MP0004782_abnormal_surfactant_physiolog | 0.79864125 |
| 101 | MP0005408_hypopigmentation | 0.79693548 |
| 102 | MP0003866_abnormal_defecation | 0.79204747 |
| 103 | MP0002332_abnormal_exercise_endurance | 0.79036659 |
| 104 | MP0001986_abnormal_taste_sensitivity | 0.78986469 |
| 105 | MP0003077_abnormal_cell_cycle | 0.78961539 |
| 106 | MP0000703_abnormal_thymus_morphology | 0.78172506 |
| 107 | MP0008004_abnormal_stomach_pH | 0.77661971 |
| 108 | MP0002933_joint_inflammation | 0.75096965 |
| 109 | MP0000371_diluted_coat_color | 0.72356170 |
| 110 | MP0009697_abnormal_copulation | 0.72013301 |
| 111 | MP0000604_amyloidosis | 0.71009126 |
| 112 | MP0003221_abnormal_cardiomyocyte_apopto | 0.70573724 |
| 113 | MP0000015_abnormal_ear_pigmentation | 0.70410420 |
| 114 | MP0001915_intracranial_hemorrhage | 0.69812264 |
| 115 | MP0009765_abnormal_xenobiotic_induced | 0.68671907 |
| 116 | MP0005075_abnormal_melanosome_morpholog | 0.68653932 |
| 117 | MP0003111_abnormal_nucleus_morphology | 0.67745403 |
| 118 | MP0008873_increased_physiological_sensi | 0.67640071 |
| 119 | MP0000372_irregular_coat_pigmentation | 0.67523119 |
| 120 | MP0005275_abnormal_skin_tensile | 0.67082372 |
| 121 | MP0005319_abnormal_enzyme/_coenzyme | 0.63380766 |
| 122 | MP0003795_abnormal_bone_structure | 0.62053707 |
| 123 | MP0002693_abnormal_pancreas_physiology | 0.57984844 |
| 124 | MP0008874_decreased_physiological_sensi | 0.53195482 |
| 125 | MP0005376_homeostasis/metabolism_phenot | 0.53144391 |
| 126 | MP0000609_abnormal_liver_physiology | 0.50559147 |
| 127 | MP0005381_digestive/alimentary_phenotyp | 0.49781776 |
| 128 | MP0002136_abnormal_kidney_physiology | 0.49033923 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.18093706 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.01385850 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.72296673 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 4.64824531 |
| 5 | Thrombocytosis (HP:0001894) | 4.23874072 |
| 6 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.14018524 |
| 7 | Myositis (HP:0100614) | 4.03404522 |
| 8 | Keratoconjunctivitis sicca (HP:0001097) | 4.00328171 |
| 9 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.92329766 |
| 10 | Autoimmune thrombocytopenia (HP:0001973) | 3.89287924 |
| 11 | Keratoconjunctivitis (HP:0001096) | 3.83224190 |
| 12 | Chronic otitis media (HP:0000389) | 3.71765479 |
| 13 | Encephalitis (HP:0002383) | 3.71640048 |
| 14 | Abnormality of macrophages (HP:0004311) | 3.68883532 |
| 15 | Vacuolated lymphocytes (HP:0001922) | 3.67295928 |
| 16 | Mediastinal lymphadenopathy (HP:0100721) | 3.56140921 |
| 17 | T lymphocytopenia (HP:0005403) | 3.53067006 |
| 18 | Abnormality of T cell number (HP:0011839) | 3.51698091 |
| 19 | Petechiae (HP:0000967) | 3.41576965 |
| 20 | Basal ganglia calcification (HP:0002135) | 3.04681838 |
| 21 | Orchitis (HP:0100796) | 3.03589547 |
| 22 | Recurrent viral infections (HP:0004429) | 3.01124490 |
| 23 | Interstitial pulmonary disease (HP:0006530) | 2.95036646 |
| 24 | Recurrent skin infections (HP:0001581) | 2.94122814 |
| 25 | Periodontitis (HP:0000704) | 2.92631867 |
| 26 | Anorexia (HP:0002039) | 2.88304543 |
| 27 | Episodic fever (HP:0001954) | 2.83864632 |
| 28 | Vasculitis (HP:0002633) | 2.83842980 |
| 29 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.78674440 |
| 30 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.78674440 |
| 31 | Abnormality of glycolipid metabolism (HP:0010969) | 2.78674440 |
| 32 | Recurrent fungal infections (HP:0002841) | 2.77911069 |
| 33 | Increased IgE level (HP:0003212) | 2.77170476 |
| 34 | Chronic obstructive pulmonary disease (HP:0006510) | 2.74954257 |
| 35 | Obstructive lung disease (HP:0006536) | 2.74954257 |
| 36 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.74741368 |
| 37 | Hypergammaglobulinemia (HP:0010702) | 2.74159060 |
| 38 | Epistaxis (HP:0000421) | 2.72426069 |
| 39 | Inflammation of the large intestine (HP:0002037) | 2.72034017 |
| 40 | Increased cerebral lipofuscin (HP:0011813) | 2.70828174 |
| 41 | Cellulitis (HP:0100658) | 2.69674214 |
| 42 | Panhypogammaglobulinemia (HP:0003139) | 2.68852392 |
| 43 | Poor head control (HP:0002421) | 2.67704471 |
| 44 | Pulmonary embolism (HP:0002204) | 2.65333621 |
| 45 | Gangrene (HP:0100758) | 2.64565370 |
| 46 | Gingival bleeding (HP:0000225) | 2.63876208 |
| 47 | Hypochromic anemia (HP:0001931) | 2.61011662 |
| 48 | Abnormality of the prostate (HP:0008775) | 2.59896219 |
| 49 | Purpura (HP:0000979) | 2.59769785 |
| 50 | Gingivitis (HP:0000230) | 2.57823283 |
| 51 | Systemic lupus erythematosus (HP:0002725) | 2.55822741 |
| 52 | Recurrent bronchitis (HP:0002837) | 2.55431281 |
| 53 | Gastrointestinal inflammation (HP:0004386) | 2.54057396 |
| 54 | Hypochromic microcytic anemia (HP:0004840) | 2.53387928 |
| 55 | Joint hemorrhage (HP:0005261) | 2.51863057 |
| 56 | Prolonged bleeding time (HP:0003010) | 2.50976996 |
| 57 | Abnormality of the pleura (HP:0002103) | 2.48829078 |
| 58 | Abnormality of the nasal mucosa (HP:0000433) | 2.46226832 |
| 59 | Arterial thrombosis (HP:0004420) | 2.45426433 |
| 60 | Pulmonary infiltrates (HP:0002113) | 2.45296050 |
| 61 | Spontaneous hematomas (HP:0007420) | 2.43832247 |
| 62 | Abnormality of T cell physiology (HP:0011840) | 2.43243226 |
| 63 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.42307588 |
| 64 | Osteolytic defects of the hand bones (HP:0009699) | 2.42307588 |
| 65 | Vertebral compression fractures (HP:0002953) | 2.42135651 |
| 66 | Subacute progressive viral hepatitis (HP:0006572) | 2.39676840 |
| 67 | Nasal polyposis (HP:0100582) | 2.39414601 |
| 68 | Amyloidosis (HP:0011034) | 2.38189063 |
| 69 | Optic neuritis (HP:0100653) | 2.37670406 |
| 70 | Retrobulbar optic neuritis (HP:0100654) | 2.37670406 |
| 71 | Osteomyelitis (HP:0002754) | 2.36698520 |
| 72 | Tetraparesis (HP:0002273) | 2.33806586 |
| 73 | Chronic diarrhea (HP:0002028) | 2.32391315 |
| 74 | Hematochezia (HP:0002573) | 2.29407651 |
| 75 | Abnormality of B cell number (HP:0010975) | 2.29250594 |
| 76 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.29179781 |
| 77 | Stomach cancer (HP:0012126) | 2.27706844 |
| 78 | Reduced antithrombin III activity (HP:0001976) | 2.26748982 |
| 79 | Pustule (HP:0200039) | 2.26567617 |
| 80 | Lymphopenia (HP:0001888) | 2.26308854 |
| 81 | Abnormality of the endocardium (HP:0004306) | 2.25749431 |
| 82 | Abnormal platelet volume (HP:0011876) | 2.25092572 |
| 83 | Peritonitis (HP:0002586) | 2.25008276 |
| 84 | Cutaneous melanoma (HP:0012056) | 2.23928584 |
| 85 | Meningitis (HP:0001287) | 2.22573105 |
| 86 | Keratitis (HP:0000491) | 2.19633483 |
| 87 | Micronodular cirrhosis (HP:0001413) | 2.18866774 |
| 88 | Increased IgM level (HP:0003496) | 2.18782331 |
| 89 | Autoimmune hemolytic anemia (HP:0001890) | 2.18658831 |
| 90 | Chest pain (HP:0100749) | 2.18616971 |
| 91 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.18536424 |
| 92 | Abnormality of eosinophils (HP:0001879) | 2.18118987 |
| 93 | Abnormality of the pericardium (HP:0001697) | 2.17690216 |
| 94 | Cervical subluxation (HP:0003308) | 2.17387968 |
| 95 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.16737228 |
| 96 | Abnormality of iron homeostasis (HP:0011031) | 2.15659530 |
| 97 | Hepatosplenomegaly (HP:0001433) | 2.15355915 |
| 98 | Glomerulopathy (HP:0100820) | 2.14737047 |
| 99 | Cheilitis (HP:0100825) | 2.14675591 |
| 100 | Spinal cord lesions (HP:0100561) | 2.13994698 |
| 101 | Syringomyelia (HP:0003396) | 2.13994698 |
| 102 | Leukocytosis (HP:0001974) | 2.12479935 |
| 103 | Urticaria (HP:0001025) | 2.11848021 |
| 104 | Vertigo (HP:0002321) | 2.11221312 |
| 105 | Hemoptysis (HP:0002105) | 2.11169708 |
| 106 | IgM deficiency (HP:0002850) | 2.11160427 |
| 107 | Polyneuropathy (HP:0001271) | 2.10993234 |
| 108 | Nausea (HP:0002018) | 2.10706862 |
| 109 | Prostate neoplasm (HP:0100787) | 2.09959322 |
| 110 | Sepsis (HP:0100806) | 2.08591093 |
| 111 | Loss of speech (HP:0002371) | 2.08378513 |
| 112 | Abnormal platelet function (HP:0011869) | 2.06452723 |
| 113 | Impaired platelet aggregation (HP:0003540) | 2.06452723 |
| 114 | Increased mean platelet volume (HP:0011877) | 2.04146003 |
| 115 | Skin ulcer (HP:0200042) | 2.03917663 |
| 116 | IgG deficiency (HP:0004315) | 2.02942011 |
| 117 | Agammaglobulinemia (HP:0004432) | 1.99631237 |
| 118 | Abnormality of T cells (HP:0002843) | 1.98469662 |
| 119 | Acute hepatic failure (HP:0006554) | 1.97931820 |
| 120 | Protrusio acetabuli (HP:0003179) | 1.97447428 |
| 121 | Viral hepatitis (HP:0006562) | 1.95555503 |
| 122 | Abnormality of the peritoneum (HP:0002585) | 1.95532441 |
| 123 | Albinism (HP:0001022) | 1.94046727 |
| 124 | Gastrointestinal infarctions (HP:0005244) | 1.93650116 |
| 125 | Microcytic anemia (HP:0001935) | 1.92247925 |
| 126 | Stomatitis (HP:0010280) | 1.91182403 |
| 127 | Amaurosis fugax (HP:0100576) | 1.91062291 |
| 128 | Acne (HP:0001061) | 1.90682182 |
| 129 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.90224613 |
| 130 | Thoracic kyphosis (HP:0002942) | 1.89736174 |
| 131 | Granulocytopenia (HP:0001913) | 1.89725198 |
| 132 | Skin rash (HP:0000988) | 1.88931561 |
| 133 | Eosinophilia (HP:0001880) | 1.88916977 |
| 134 | Abnormality of the common coagulation pathway (HP:0010990) | 1.88689063 |
| 135 | Axonal loss (HP:0003447) | 1.88598742 |
| 136 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.88012698 |
| 137 | Recurrent lower respiratory tract infections (HP:0002783) | 1.87696334 |
| 138 | Increased serum ferritin (HP:0003281) | 1.87601972 |
| 139 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.87113925 |
| 140 | Bruising susceptibility (HP:0000978) | 1.86649583 |
| 141 | Recurrent pneumonia (HP:0006532) | 1.86635351 |
| 142 | Nonimmune hydrops fetalis (HP:0001790) | 1.85929239 |
| 143 | Recurrent cutaneous fungal infections (HP:0011370) | 1.85778401 |
| 144 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.85778401 |
| 145 | Reticulocytopenia (HP:0001896) | 1.85761654 |
| 146 | Myocardial infarction (HP:0001658) | 1.85406177 |
| 147 | IgA deficiency (HP:0002720) | 1.84284083 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TBK1 | 3.14234010 |
| 2 | PIM2 | 3.11393356 |
| 3 | KIT | 3.00033485 |
| 4 | IRAK4 | 2.79459670 |
| 5 | TYK2 | 2.72160347 |
| 6 | MAP3K14 | 2.61058785 |
| 7 | NME2 | 2.56889446 |
| 8 | BLK | 2.56405480 |
| 9 | MAP4K1 | 2.48954701 |
| 10 | IRAK3 | 2.41220691 |
| 11 | IKBKE | 2.37962599 |
| 12 | JAK3 | 2.18976881 |
| 13 | ERN1 | 2.17805425 |
| 14 | NEK9 | 2.08178539 |
| 15 | GRK6 | 2.02057393 |
| 16 | TNK2 | 1.98768835 |
| 17 | TEC | 1.93931566 |
| 18 | PKN2 | 1.77056774 |
| 19 | FGR | 1.74837177 |
| 20 | IKBKB | 1.72369133 |
| 21 | RPS6KA4 | 1.64305451 |
| 22 | MAP2K3 | 1.58226619 |
| 23 | JAK1 | 1.52708492 |
| 24 | MAP3K3 | 1.51517220 |
| 25 | TAOK1 | 1.50061506 |
| 26 | FLT3 | 1.48352640 |
| 27 | ZAP70 | 1.46961455 |
| 28 | MST1R | 1.45954178 |
| 29 | BTK | 1.43604654 |
| 30 | TAOK3 | 1.41996162 |
| 31 | PIM1 | 1.41460958 |
| 32 | KDR | 1.39474378 |
| 33 | PRPF4B | 1.37860368 |
| 34 | BMPR2 | 1.35859393 |
| 35 | CSF1R | 1.31970292 |
| 36 | TGFBR1 | 1.31690004 |
| 37 | PBK | 1.30327711 |
| 38 | ABL2 | 1.27356549 |
| 39 | EIF2AK3 | 1.26259482 |
| 40 | FRK | 1.25545090 |
| 41 | TRIB3 | 1.19192053 |
| 42 | TXK | 1.16960806 |
| 43 | WEE1 | 1.16441903 |
| 44 | LRRK2 | 1.16076080 |
| 45 | SIK3 | 1.15953988 |
| 46 | RIPK4 | 1.15816496 |
| 47 | SYK | 1.11880271 |
| 48 | MATK | 1.10101855 |
| 49 | TRPM7 | 1.09696186 |
| 50 | STK10 | 1.08621673 |
| 51 | EIF2AK2 | 1.07231560 |
| 52 | MAP3K1 | 1.05017264 |
| 53 | KSR2 | 1.01127020 |
| 54 | VRK1 | 1.00464712 |
| 55 | ACVR1B | 0.99242866 |
| 56 | CHUK | 0.95582732 |
| 57 | YES1 | 0.94869448 |
| 58 | IRAK2 | 0.92879933 |
| 59 | GRK7 | 0.92197382 |
| 60 | BMX | 0.92170803 |
| 61 | MAP2K6 | 0.91328475 |
| 62 | TESK1 | 0.91221831 |
| 63 | LYN | 0.90849762 |
| 64 | HCK | 0.86680310 |
| 65 | STK4 | 0.86529113 |
| 66 | EPHA3 | 0.86214537 |
| 67 | PTK2B | 0.86167519 |
| 68 | FES | 0.84763112 |
| 69 | BRSK2 | 0.84230558 |
| 70 | EIF2AK1 | 0.83686849 |
| 71 | EPHB1 | 0.83500582 |
| 72 | ADRBK2 | 0.83129599 |
| 73 | LCK | 0.82920200 |
| 74 | TGFBR2 | 0.81524414 |
| 75 | MAP3K5 | 0.79697143 |
| 76 | PAK4 | 0.78834727 |
| 77 | SCYL2 | 0.77967805 |
| 78 | ARAF | 0.77807613 |
| 79 | PDK1 | 0.77750894 |
| 80 | STK16 | 0.77210804 |
| 81 | MARK3 | 0.75758652 |
| 82 | TTN | 0.75732610 |
| 83 | CSK | 0.75396433 |
| 84 | CDC7 | 0.72395623 |
| 85 | SIK2 | 0.70693215 |
| 86 | FGFR4 | 0.70527167 |
| 87 | PTK6 | 0.69537709 |
| 88 | PIK3CG | 0.69280131 |
| 89 | EEF2K | 0.69206772 |
| 90 | PRKCQ | 0.69086038 |
| 91 | ATR | 0.68827711 |
| 92 | MAP3K8 | 0.66143180 |
| 93 | MAP3K13 | 0.66080268 |
| 94 | TAOK2 | 0.65945045 |
| 95 | CDK4 | 0.64418106 |
| 96 | RIPK1 | 0.64367733 |
| 97 | PRKD2 | 0.64011152 |
| 98 | RAF1 | 0.62349562 |
| 99 | CDC42BPA | 0.62149961 |
| 100 | MAP3K11 | 0.61477692 |
| 101 | PDPK1 | 0.60969425 |
| 102 | JAK2 | 0.60908475 |
| 103 | HIPK2 | 0.58362145 |
| 104 | PRKG2 | 0.57735202 |
| 105 | MARK2 | 0.56059723 |
| 106 | ABL1 | 0.56020754 |
| 107 | MAP3K6 | 0.55806386 |
| 108 | CDK6 | 0.55785013 |
| 109 | MST4 | 0.53768716 |
| 110 | TESK2 | 0.53248323 |
| 111 | STK3 | 0.53023375 |
| 112 | FYN | 0.52330644 |
| 113 | FGFR3 | 0.52284888 |
| 114 | MAPK7 | 0.51294591 |
| 115 | RPS6KA6 | 0.49620500 |
| 116 | MAP3K12 | 0.49597690 |
| 117 | KSR1 | 0.49518566 |
| 118 | NLK | 0.48415529 |
| 119 | AURKB | 0.46494112 |
| 120 | CDK7 | 0.45883967 |
| 121 | MAP3K7 | 0.45530550 |
| 122 | IRAK1 | 0.44473055 |
| 123 | CAMKK2 | 0.44025298 |
| 124 | MAPKAPK3 | 0.43688176 |
| 125 | MKNK1 | 0.43602787 |
| 126 | NEK2 | 0.41813559 |
| 127 | PRKCD | 0.40929131 |
| 128 | RPS6KB2 | 0.39992697 |
| 129 | ADRBK1 | 0.38915097 |
| 130 | PRKAA2 | 0.38795085 |
| 131 | TIE1 | 0.38722605 |
| 132 | MAPK12 | 0.38632224 |
| 133 | MAPK4 | 0.37878375 |
| 134 | MAPKAPK2 | 0.37354891 |
| 135 | MAPK11 | 0.36567400 |
| 136 | CLK1 | 0.35386069 |
| 137 | ITK | 0.35269520 |
| 138 | STK11 | 0.34007329 |
| 139 | DAPK2 | 0.33717219 |
| 140 | SGK3 | 0.29829203 |
| 141 | TLK1 | 0.29034248 |
| 142 | MAP3K2 | 0.28032454 |
| 143 | PRKCZ | 0.25821706 |
| 144 | RPS6KC1 | 0.21412663 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.98456137 |
| 2 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.87945097 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 2.54845091 |
| 4 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.45004063 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.44557609 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.30626814 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.11621629 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.04154030 |
| 9 | Legionellosis_Homo sapiens_hsa05134 | 1.99593192 |
| 10 | Malaria_Homo sapiens_hsa05144 | 1.97030189 |
| 11 | Pertussis_Homo sapiens_hsa05133 | 1.94088298 |
| 12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.90493819 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.89652198 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.83815150 |
| 15 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.83768547 |
| 16 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.81675517 |
| 17 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.79950814 |
| 18 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.78153296 |
| 19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.72368643 |
| 20 | Influenza A_Homo sapiens_hsa05164 | 1.71551309 |
| 21 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.68091019 |
| 22 | Tuberculosis_Homo sapiens_hsa05152 | 1.56188795 |
| 23 | Proteasome_Homo sapiens_hsa03050 | 1.55174370 |
| 24 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.53932409 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.53470488 |
| 26 | Shigellosis_Homo sapiens_hsa05131 | 1.48367773 |
| 27 | Apoptosis_Homo sapiens_hsa04210 | 1.47284758 |
| 28 | Asthma_Homo sapiens_hsa05310 | 1.46251989 |
| 29 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.43463949 |
| 30 | * TNF signaling pathway_Homo sapiens_hsa04668 | 1.43319440 |
| 31 | Other glycan degradation_Homo sapiens_hsa00511 | 1.42019643 |
| 32 | Base excision repair_Homo sapiens_hsa03410 | 1.36203947 |
| 33 | Salmonella infection_Homo sapiens_hsa05132 | 1.31269086 |
| 34 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.28607906 |
| 35 | Viral myocarditis_Homo sapiens_hsa05416 | 1.26407068 |
| 36 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.22310291 |
| 37 | Ribosome_Homo sapiens_hsa03010 | 1.20995123 |
| 38 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.19560329 |
| 39 | Mismatch repair_Homo sapiens_hsa03430 | 1.19547213 |
| 40 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.16969497 |
| 41 | Hepatitis B_Homo sapiens_hsa05161 | 1.16561473 |
| 42 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.13253759 |
| 43 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.11007071 |
| 44 | Lysosome_Homo sapiens_hsa04142 | 1.10761747 |
| 45 | Phagosome_Homo sapiens_hsa04145 | 1.09662296 |
| 46 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.08323152 |
| 47 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.07700219 |
| 48 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.06523293 |
| 49 | Homologous recombination_Homo sapiens_hsa03440 | 1.04090575 |
| 50 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.01324982 |
| 51 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.00891838 |
| 52 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.00392197 |
| 53 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.00114509 |
| 54 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.96957669 |
| 55 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.95990221 |
| 56 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.92433019 |
| 57 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.90472471 |
| 58 | Hepatitis C_Homo sapiens_hsa05160 | 0.89954915 |
| 59 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.89924404 |
| 60 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.88610348 |
| 61 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.85504288 |
| 62 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.84587062 |
| 63 | Platelet activation_Homo sapiens_hsa04611 | 0.83780439 |
| 64 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.82681194 |
| 65 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.80819009 |
| 66 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.80566762 |
| 67 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.78977396 |
| 68 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.78809232 |
| 69 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.78400262 |
| 70 | Galactose metabolism_Homo sapiens_hsa00052 | 0.78265723 |
| 71 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.77518654 |
| 72 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.75725154 |
| 73 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.75143511 |
| 74 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.73779531 |
| 75 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.73602715 |
| 76 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.73325558 |
| 77 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.71258924 |
| 78 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.70901189 |
| 79 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.70888978 |
| 80 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.70400684 |
| 81 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.69401416 |
| 82 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.68175404 |
| 83 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.66646675 |
| 84 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.65032346 |
| 85 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.64589053 |
| 86 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.63665216 |
| 87 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.63508078 |
| 88 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.62496811 |
| 89 | Cell cycle_Homo sapiens_hsa04110 | 0.62215556 |
| 90 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.61531318 |
| 91 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.60288072 |
| 92 | Amoebiasis_Homo sapiens_hsa05146 | 0.60069021 |
| 93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59295902 |
| 94 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58653780 |
| 95 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.57447640 |
| 96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.54802896 |
| 97 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.54415816 |
| 98 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.53934161 |
| 99 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.53682430 |
| 100 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.52756139 |
| 101 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52036875 |
| 102 | Endocytosis_Homo sapiens_hsa04144 | 0.51922628 |
| 103 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.51719958 |
| 104 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.51515847 |
| 105 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.47741630 |
| 106 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.46980198 |
| 107 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.46085641 |
| 108 | Insulin resistance_Homo sapiens_hsa04931 | 0.45604598 |
| 109 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.44264146 |
| 110 | HTLV-I infection_Homo sapiens_hsa05166 | 0.41688547 |
| 111 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.41317121 |
| 112 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.39903210 |
| 113 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.39890445 |
| 114 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.38731340 |
| 115 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.38709533 |
| 116 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.38382842 |
| 117 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.37596813 |
| 118 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.37558044 |
| 119 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.37214118 |
| 120 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.37127094 |
| 121 | Protein export_Homo sapiens_hsa03060 | 0.36885290 |
| 122 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36745157 |
| 123 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.36594689 |
| 124 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.35768164 |
| 125 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.35754337 |
| 126 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.34909345 |
| 127 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.32826471 |
| 128 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.31320228 |
| 129 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.26239596 |
| 130 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.23768840 |
| 131 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23424592 |
| 132 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.22426136 |
| 133 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.22334145 |

